OpenAI Unveils GPT-Rosalind for Neurodegenerative Drug Discovery
OpenAI, partnering with PerturbAI and Scripps Research, unveiled GPT-Rosalind, demonstrating how AI can help scientists discover new targets for understanding and treating neurodegenerative diseases, including findings around the DCTN1 gene.
2026-11-21 ~ 2026-11-21 · 2 related posts